{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:59:13Z","timestamp":1782255553043,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,9,30]],"date-time":"2015-09-30T00:00:00Z","timestamp":1443571200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,9,30]],"date-time":"2015-09-30T00:00:00Z","timestamp":1443571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["5T32 CA106493-09"],"award-info":[{"award-number":["5T32 CA106493-09"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["F31 DK104492-01A"],"award-info":[{"award-number":["F31 DK104492-01A"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["T90 DE021990-02"],"award-info":[{"award-number":["T90 DE021990-02"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cracchiolo Foundation"},{"name":"Frederick A. Coller Surgical Society"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s00262-015-1760-y","type":"journal-article","created":{"date-parts":[[2015,9,30]],"date-time":"2015-09-30T06:27:25Z","timestamp":1443594445000},"page":"1553-1563","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Downstream mediators of the intratumoral interferon response suppress antitumor immunity, induce gemcitabine resistance and associate with poor survival in human pancreatic cancer"],"prefix":"10.1007","volume":"64","author":[{"given":"Daniel","family":"Delitto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsey","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Gonzalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kien","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea E.","family":"Knowlton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina L.","family":"Graves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin E.","family":"Behrns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyle L.","family":"Moldawer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan M.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Thomas J.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose G.","family":"Trevino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon M.","family":"Wallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,30]]},"reference":[{"key":"1760_CR1","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74:2913\u20132921. doi:\n                    10.1158\/0008-5472.CAN-14-0155","journal-title":"Cancer Res"},{"key":"1760_CR2","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","volume":"369","author":"DD Von Hoff","year":"2013","unstructured":"Von Hoff DD, Ervin T, Arena FP et al (2013) Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 369:1691\u20131703. doi:\n                    10.1056\/NEJMoa1304369","journal-title":"N Engl J Med"},{"key":"1760_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1084\/jem.20031435","volume":"200","author":"AM Thomas","year":"2004","unstructured":"Thomas AM, Santarsiero LM, Lutz ER et al (2004) Mesothelin-specific CD8(+) T cell responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patients. J Exp Med 200:297\u2013306. doi:\n                    10.1084\/jem.20031435","journal-title":"J Exp Med"},{"key":"1760_CR4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1158\/2326-6066.CIR-14-0215","volume":"3","author":"R Winograd","year":"2015","unstructured":"Winograd R, Byrne KT, Evans RA et al (2015) Induction of T-cell immunity overcomes complete resistance to PD-1 and CTLA-4 blockade and improves survival in pancreatic carcinoma. Cancer Immunol Res 3:399\u2013411. doi:\n                    10.1158\/2326-6066.CIR-14-0215","journal-title":"Cancer Immunol Res"},{"key":"1760_CR5","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/CJI.0b013e31829fb7a2","volume":"36","author":"DT Le","year":"2013","unstructured":"Le DT, Lutz E, Uram JN et al (2013) Evaluation of ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene in previously treated pancreatic cancer. J Immunother 36:382\u2013389. doi:\n                    10.1097\/CJI.0b013e31829fb7a2","journal-title":"J Immunother"},{"key":"1760_CR6","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1097\/CJI.0b013e3181eec14c","volume":"33","author":"RE Royal","year":"2010","unstructured":"Royal RE, Levy C, Turner K et al (2010) Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma. J Immunother 33:828\u2013833. doi:\n                    10.1097\/CJI.0b013e3181eec14c","journal-title":"J Immunother"},{"key":"1760_CR7","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1126\/science.1195300","volume":"330","author":"M Kraman","year":"2010","unstructured":"Kraman M, Bambrough PJ, Arnold JN, Roberts EW, Magiera L, Jones JO, Gopinathan A, Tuveson DA, Fearon DT (2010) Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha. Science 330:827\u2013830. doi:\n                    10.1126\/science.1195300","journal-title":"Science"},{"key":"1760_CR8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nrc1630","volume":"5","author":"D Laheru","year":"2005","unstructured":"Laheru D, Jaffee EM (2005) Immunotherapy for pancreatic cancer\u2014science driving clinical progress. Nat Rev Cancer 5:459\u2013467. doi:\n                    10.1038\/nrc1630","journal-title":"Nat Rev Cancer"},{"key":"1760_CR9","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/nrgastro.2012.115","volume":"9","author":"M Erkan","year":"2012","unstructured":"Erkan M, Hausmann S, Michalski CW, Fingerle AA, Dobritz M, Kleeff J, Friess H (2012) The role of stroma in pancreatic cancer: diagnostic and therapeutic implications. Nat Rev Gastroenterol Hepatol 9:454\u2013467. doi:\n                    10.1038\/nrgastro.2012.115","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1760_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1053\/j.gastro.2015.04.010","volume":"149","author":"GL Beatty","year":"2015","unstructured":"Beatty GL, Winograd R, Evans RA et al (2015) Exclusion of T cells from pancreatic carcinomas in mice is regulated by Ly6C(low) F4\/80(+) extratumoral macrophages. Gastroenterology 149:201\u2013210. doi:\n                    10.1053\/j.gastro.2015.04.010","journal-title":"Gastroenterology"},{"key":"1760_CR11","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ccr.2012.04.025","volume":"21","author":"LJ Bayne","year":"2012","unstructured":"Bayne LJ, Beatty GL, Jhala N, Clark CE, Rhim AD, Stanger BZ, Vonderheide RH (2012) Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell 21:822\u2013835. doi:\n                    10.1016\/j.ccr.2012.04.025","journal-title":"Cancer Cell"},{"key":"1760_CR12","doi-asserted-by":"publisher","first-page":"9518","DOI":"10.1158\/0008-5472.CAN-07-0175","volume":"67","author":"CE Clark","year":"2007","unstructured":"Clark CE, Hingorani SR, Mick R, Combs C, Tuveson DA, Vonderheide RH (2007) Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Cancer Res 67:9518\u20139527. doi:\n                    10.1158\/0008-5472.CAN-07-0175","journal-title":"Cancer Res"},{"key":"1760_CR13","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nrm2455","volume":"9","author":"M Schafer","year":"2008","unstructured":"Schafer M, Werner S (2008) Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol 9:628\u2013638. doi:\n                    10.1038\/nrm2455","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1760_CR14","doi-asserted-by":"publisher","first-page":"7556","DOI":"10.1073\/pnas.95.13.7556","volume":"95","author":"DH Kaplan","year":"1998","unstructured":"Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ, Schreiber RD (1998) Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci USA 95:7556\u20137561","journal-title":"Proc Natl Acad Sci USA"},{"key":"1760_CR15","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nm0902-1039c","volume":"8","author":"H Dong","year":"2002","unstructured":"Dong H, Strome SE, Salomao DR et al (2002) Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 8:793\u2013800. doi:\n                    10.1038\/nm730","journal-title":"Nat Med"},{"key":"1760_CR16","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1146\/annurev.immunol.15.1.749","volume":"15","author":"U Boehm","year":"1997","unstructured":"Boehm U, Klamp T, Groot M, Howard JC (1997) Cellular responses to interferon-gamma. Annu Rev Immunol 15:749\u2013795. doi:\n                    10.1146\/annurev.immunol.15.1.749","journal-title":"Annu Rev Immunol"},{"key":"1760_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/sj.neo.7900005","volume":"1","author":"CJ Bruns","year":"1999","unstructured":"Bruns CJ, Harbison MT, Kuniyasu H, Eue I, Fidler IJ (1999) In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice. Neoplasia 1:50\u201362","journal-title":"Neoplasia"},{"key":"1760_CR18","doi-asserted-by":"publisher","first-page":"7214","DOI":"10.1158\/0008-5472.CAN-04-3858","volume":"65","author":"JG Trevino","year":"2005","unstructured":"Trevino JG, Summy JM, Gray MJ, Nilsson MB, Lesslie DP, Baker CH, Gallick GE (2005) Expression and activity of SRC regulate interleukin-8 expression in pancreatic adenocarcinoma cells: implications for angiogenesis. Cancer Res 65:7214\u20137222. doi:\n                    10.1158\/0008-5472.CAN-04-3858","journal-title":"Cancer Res"},{"key":"1760_CR19","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1158\/1535-7163.MCT-12-0719","volume":"12","author":"JG Trevino","year":"2013","unstructured":"Trevino JG, Verma M, Singh S et al (2013) Selective disruption of rb-raf-1 kinase interaction inhibits pancreatic adenocarcinoma growth irrespective of gemcitabine sensitivity. Mol Cancer Ther 12:2722\u20132734. doi:\n                    10.1158\/1535-7163.MCT-12-0719","journal-title":"Mol Cancer Ther"},{"key":"1760_CR20","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.ajpath.2015.01.016","volume":"185","author":"D Delitto","year":"2015","unstructured":"Delitto D, Pham K, Vlada AC et al (2015) Patient-derived xenograft models for pancreatic adenocarcinoma demonstrate retention of tumor morphology through incorporation of murine stromal elements. Am J Pathol 185:1297\u20131303. doi:\n                    10.1016\/j.ajpath.2015.01.016","journal-title":"Am J Pathol"},{"key":"1760_CR21","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0016-5085(98)70209-4","volume":"115","author":"MG Bachem","year":"1998","unstructured":"Bachem MG, Schneider E, Gross H et al (1998) Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 115:421\u2013432","journal-title":"Gastroenterology"},{"key":"1760_CR22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fimmu.2015.00094","volume":"6","author":"H Meng","year":"2015","unstructured":"Meng H, Lee Y, Ba Z, Fleming JA, Furumoto EJ, Roberts RF, Kris-Etherton PM, Rogers CJ (2015) In vitro production of IL-6 and IFN-gamma is influenced by dietary variables and predicts upper respiratory tract infection incidence and severity respectively in young adults. Front Immunol 6:94. doi:\n                    10.3389\/fimmu.2015.00094","journal-title":"Front Immunol"},{"key":"1760_CR23","doi-asserted-by":"publisher","first-page":"982","DOI":"10.2119\/molmed.2011.00513","volume":"18","author":"X Li","year":"2012","unstructured":"Li X, Rendon JL, Akhtar S, Choudhry MA (2012) Activation of toll-like receptor 2 prevents suppression of T-cell interferon gamma production by modulating p38\/extracellular signal-regulated kinase pathways following alcohol and burn injury. Mol Med 18:982\u2013991. doi:\n                    10.2119\/molmed.2011.00513","journal-title":"Mol Med"},{"key":"1760_CR24","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1046\/j.1365-3083.1999.00617.x","volume":"50","author":"CM Verhoef","year":"1999","unstructured":"Verhoef CM, Van Roon JA, Vianen ME, Glaudemans CA, Lafeber FP, Bijlsma JW (1999) Lymphocyte stimulation by CD3-CD28 enables detection of low T cell interferon-gamma and interleukin-4 production in rheumatoid arthritis. Scand J Immunol 50:427\u2013432","journal-title":"Scand J Immunol"},{"key":"1760_CR25","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1158\/0008-5472.CAN-08-2819","volume":"69","author":"T Arumugam","year":"2009","unstructured":"Arumugam T, Ramachandran V, Fournier KF et al (2009) Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res 69:5820\u20135828. doi:\n                    10.1158\/0008-5472.CAN-08-2819","journal-title":"Cancer Res"},{"key":"1760_CR26","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1593\/neo.121044","volume":"14","author":"JG Trevino","year":"2012","unstructured":"Trevino JG, Pillai S, Kunigal S, Singh S, Fulp WJ, Centeno BA, Chellappan SP (2012) Nicotine induces inhibitor of differentiation-1 in a Src-dependent pathway promoting metastasis and chemoresistance in pancreatic adenocarcinoma. Neoplasia 14:1102\u20131114","journal-title":"Neoplasia"},{"key":"1760_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1172\/JCI9775","volume":"107","author":"P Romagnani","year":"2001","unstructured":"Romagnani P, Annunziato F, Lasagni L et al (2001) Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J Clin Invest 107:53\u201363. doi:\n                    10.1172\/JCI9775","journal-title":"J Clin Invest"},{"key":"1760_CR28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejphar.2014.07.041","volume":"741","author":"Cavalcante L de Sousa","year":"2014","unstructured":"de Sousa Cavalcante L, Monteiro G (2014) Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer. Eur J Pharmacol 741:8\u201316. doi:\n                    10.1016\/j.ejphar.2014.07.041","journal-title":"Eur J Pharmacol"},{"key":"1760_CR29","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/ijc.22871","volume":"121","author":"J Kleeff","year":"2007","unstructured":"Kleeff J, Beckhove P, Esposito I, Herzig S, Huber PE, Lohr JM, Friess H (2007) Pancreatic cancer microenvironment. Int J Cancer 121:699\u2013705. doi:\n                    10.1002\/ijc.22871","journal-title":"Int J Cancer"},{"key":"1760_CR30","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1016\/j.pan.2015.02.013","volume":"15","author":"MV Apte","year":"2015","unstructured":"Apte MV, Xu Z, Pothula S, Goldstein D, Pirola RC, Wilson JS (2015) Pancreatic cancer: the microenvironment needs attention too! Pancreatology 15:S32\u2013S38. doi:\n                    10.1016\/j.pan.2015.02.013","journal-title":"Pancreatology"},{"key":"1760_CR31","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1136\/gutjnl-2015-309304","volume":"64","author":"A Neesse","year":"2015","unstructured":"Neesse A, Algul H, Tuveson DA, Gress TM (2015) Stromal biology and therapy in pancreatic cancer: a changing paradigm. Gut 64:1476\u20131484. doi:\n                    10.1136\/gutjnl-2015-309304","journal-title":"Gut"},{"key":"1760_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1476-4598-10-13","volume":"10","author":"F Lange","year":"2011","unstructured":"Lange F, Rateitschak K, Fitzner B, Pohland R, Wolkenhauer O, Jaster R (2011) Studies on mechanisms of interferon-gamma action in pancreatic cancer using a data-driven and model-based approach. Mol Cancer 10:13. doi:\n                    10.1186\/1476-4598-10-13","journal-title":"Mol Cancer"},{"key":"1760_CR33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nature03954","volume":"437","author":"G Willimsky","year":"2005","unstructured":"Willimsky G, Blankenstein T (2005) Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance. Nature 437:141\u2013146. doi:\n                    10.1038\/nature03954","journal-title":"Nature"},{"key":"1760_CR34","doi-asserted-by":"publisher","first-page":"8368","DOI":"10.1158\/0008-5472.CAN-10-1322","volume":"70","author":"R Bos","year":"2010","unstructured":"Bos R, Sherman LA (2010) CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes. Cancer Res 70:8368\u20138377. doi:\n                    10.1158\/0008-5472.CAN-10-1322","journal-title":"Cancer Res"},{"key":"1760_CR35","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1158\/0008-5472.CAN-03-3259","volume":"64","author":"C Blank","year":"2004","unstructured":"Blank C, Brown I, Peterson AC, Spiotto M, Iwai Y, Honjo T, Gajewski TF (2004) PD-L1\/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells. Cancer Res 64:1140\u20131145","journal-title":"Cancer Res"},{"key":"1760_CR36","doi-asserted-by":"publisher","first-page":"20212","DOI":"10.1073\/pnas.1320318110","volume":"110","author":"C Feig","year":"2013","unstructured":"Feig C, Jones JO, Kraman M et al (2013) Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. Proc Natl Acad Sci USA 110:20212\u201320217. doi:\n                    10.1073\/pnas.1320318110","journal-title":"Proc Natl Acad Sci USA"},{"key":"1760_CR37","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1158\/1078-0432.CCR-13-2972","volume":"20","author":"N Hartmann","year":"2014","unstructured":"Hartmann N, Giese NA, Giese T, Poschke I, Offringa R, Werner J, Ryschich E (2014) Prevailing role of contact guidance in intrastromal T-cell trapping in human pancreatic cancer. Clin Cancer Res 20:3422\u20133433. doi:\n                    10.1158\/1078-0432.CCR-13-2972","journal-title":"Clin Cancer Res"},{"key":"1760_CR38","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s00011-013-0645-9","volume":"62","author":"B Lakshmi Narendra","year":"2013","unstructured":"Lakshmi Narendra B, Eshvendar Reddy K, Shantikumar S, Ramakrishna S (2013) Immune system: a double-edged sword in cancer. Inflamm Res 62:823\u2013834. doi:\n                    10.1007\/s00011-013-0645-9","journal-title":"Inflamm Res"},{"key":"1760_CR39","doi-asserted-by":"publisher","first-page":"11064","DOI":"10.18632\/oncotarget.2519","volume":"5","author":"S Lunardi","year":"2014","unstructured":"Lunardi S, Jamieson NB, Lim SY et al (2014) IP-10\/CXCL10 induction in human pancreatic cancer stroma influences lymphocytes recruitment and correlates with poor survival. Oncotarget 5:11064\u201311080","journal-title":"Oncotarget"},{"key":"1760_CR40","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1172\/JCI64993","volume":"123","author":"P Chaturvedi","year":"2013","unstructured":"Chaturvedi P, Gilkes DM, Wong CC et al (2013) Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis. J Clin Invest 123:189\u2013205. doi:\n                    10.1172\/JCI64993","journal-title":"J Clin Invest"},{"key":"1760_CR41","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1158\/0008-5472.CAN-06-3087","volume":"67","author":"A Zipin-Roitman","year":"2007","unstructured":"Zipin-Roitman A, Meshel T, Sagi-Assif O, Shalmon B, Avivi C, Pfeffer RM, Witz IP, Ben-Baruch A (2007) CXCL10 promotes invasion-related properties in human colorectal carcinoma cells. Cancer Res 67:3396\u20133405. doi:\n                    10.1158\/0008-5472.CAN-06-3087","journal-title":"Cancer Res"},{"key":"1760_CR42","doi-asserted-by":"publisher","first-page":"7701","DOI":"10.1158\/0008-5472.CAN-06-0709","volume":"66","author":"TC Walser","year":"2006","unstructured":"Walser TC, Rifat S, Ma X et al (2006) Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer. Cancer Res 66:7701\u20137707. doi:\n                    10.1158\/0008-5472.CAN-06-0709","journal-title":"Cancer Res"},{"key":"1760_CR43","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1158\/0008-5472.CAN-03-1757","volume":"64","author":"K Kawada","year":"2004","unstructured":"Kawada K, Sonoshita M, Sakashita H et al (2004) Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes. Cancer Res 64:4010\u20134017. doi:\n                    10.1158\/0008-5472.CAN-03-1757","journal-title":"Cancer Res"},{"key":"1760_CR44","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.3390\/cancers6042137","volume":"6","author":"M Schober","year":"2014","unstructured":"Schober M, Jesenofsky R, Faissner R, Weidenauer C, Hagmann W, Michl P, Heuchel RL, Haas SL, Lohr JM (2014) Desmoplasia and chemoresistance in pancreatic cancer. Cancers (Basel) 6:2137\u20132154. doi:\n                    10.3390\/cancers6042137","journal-title":"Cancers (Basel)"},{"key":"1760_CR45","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1245\/s10434-007-9583-5","volume":"14","author":"AN Shah","year":"2007","unstructured":"Shah AN, Summy JM, Zhang J, Park SI, Parikh NU, Gallick GE (2007) Development and characterization of gemcitabine-resistant pancreatic tumor cells. Ann Surg Oncol 14:3629\u20133637. doi:\n                    10.1245\/s10434-007-9583-5","journal-title":"Ann Surg Oncol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-015-1760-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-015-1760-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-015-1760-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-015-1760-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T11:13:11Z","timestamp":1589627591000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-015-1760-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,30]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1760"],"URL":"https:\/\/doi.org\/10.1007\/s00262-015-1760-y","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,30]]},"assertion":[{"value":"26 June 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}